US Stock MarketDetailed Quotes
ATHE Alterity Therapeutics
- 1.2000
- -0.0500-4.00%
Close Oct 17 16:00 ET
- 1.2000
- 0.00000.00%
Post 20:02 ET
10.49MMarket Cap-574P/E (TTM)
1.2761High1.2000Low9.14KVolume1.2550Open1.2500Pre Close11.40KTurnover0.14%Turnover RatioLossP/E (Static)8.74MShares5.410052wk High1.14P/B7.74MFloat Cap1.010052wk Low--Dividend TTM6.45MShs Float51.5000Historical High--Div YieldTTM6.09%Amplitude1.0100Historical Low1.2470Avg Price1Lot Size
Alterity Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 37.08%-12.61M | -62.40%-20.04M | ||||||||
| Net income from continuing operations | -38.51%-19.12M | ---- | ---- | ---- | ---- | -7.47%-13.81M | ---- | ---- | ---- | ---- |
| Operating gains losses | 71.54%-261.15K | ---- | ---- | ---- | ---- | 67.39%-917.65K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 44.26%147.53K | ---- | ---- | ---- | ---- | 88.63%102.26K | ---- | ---- | ---- | ---- |
| Change In working capital | 189.96%5.75M | ---- | ---- | ---- | ---- | -462.49%-6.39M | ---- | ---- | ---- | ---- |
| -Change in receivables | 217.35%4.62M | ---- | ---- | ---- | ---- | -780.16%-3.94M | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 170.62%1.1M | ---- | ---- | ---- | ---- | -159.94%-1.56M | ---- | ---- | ---- | ---- |
| -Change in other current assets | 126.13%252.99K | ---- | ---- | ---- | ---- | -87.57%-968.21K | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | ---11.94K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in other working capital | -377.06%-218.01K | ---- | ---- | ---- | ---- | -35.97%78.69K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 37.08%-12.61M | ---- | ---- | ---- | ---- | -62.40%-20.04M | ---- | ---- | ---- | ---- |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 84.31%-5.72K | 97.28%-722 | 0 | 79.50%-1K | -4K | 59.10%-36.46K | 70.18%-26.58K | -5K | -90.58%-4.88K | 0 |
| Net PPE purchase and sale | 21.73%-5.72K | -128.14%-722 | --0 | 79.50%-1K | ---4K | 91.80%-7.31K | 102.88%2.57K | ---5K | -90.58%-4.88K | --0 |
| Net intangibles purchase and sale | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Net business purchase and sale | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Net investment purchase and sale | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---29.15K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 84.31%-5.72K | 97.28%-722 | --0 | 79.50%-1K | ---4K | 59.10%-36.46K | 70.18%-26.58K | ---5K | -90.58%-4.88K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 7,312.17%9.22M | 196.32%12.29K | 6,501.60%8.25M | 990.74%970K | -114.05%-17K | -99.24%124.34K | 95.53%-12.76K | 12,400.00%125K | 59.51%-108.9K | -99.27%121K |
| Net issuance payments of debt | 82.69%-10.37K | 67.75%-10.37K | --0 | --0 | --0 | -73.62%-59.92K | 6.84%-32.15K | --0 | -16.89%-27.77K | --0 |
| Net common stock issuance | 3,103.50%10.14M | 1,523.21%94.68K | 4,803.30%8.92M | 712,758.23%1.13M | --0 | -98.16%316.68K | 14,482.50%5.83K | --182K | -495.00%-158 | -99.25%129K |
| Cash dividends paid | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --0 | ---- | --0 |
| Net other financing activities | -593.30%-918.02K | -631.16%-72.02K | -1,080.70%-673K | -92.66%-156K | -112.50%-17K | 84.18%-132.41K | 105.40%13.56K | -5,800.00%-57K | 66.98%-80.97K | 98.58%-8K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 7,312.17%9.22M | 196.32%12.29K | 6,500.80%8.25M | 990.74%970K | -114.05%-17K | -99.24%124.34K | 95.53%-12.76K | 12,400.00%125K | 59.51%-108.9K | -99.27%121K |
| Net cash flow | ||||||||||
| Beginning cash position | -54.68%15.77M | -16.60%18.3M | -51.40%12.32M | -47.54%16.71M | -54.68%15.77M | 23.80%34.81M | -32.76%21.94M | -31.49%25.35M | -22.95%31.85M | 23.80%34.81M |
| Current changes in cash | 82.98%-3.4M | 8.71%-5.7M | 249.95%5.67M | 26.14%-3.89M | 111.37%528K | -614.37%-19.95M | -1,645.52%-6.25M | -10.94%-3.78M | -30.23%-5.27M | -139.64%-4.65M |
| Effect of exchange rate changes | -71.54%260.36K | -55.33%39.36K | -18.78%307K | 60.05%-495K | -75.83%408K | -67.48%914.94K | -96.52%88.1K | 139.54%378K | -336.73%-1.24M | 12.38%1.69M |
| End cash Position | -19.87%12.64M | -19.87%12.64M | -16.60%18.3M | -51.38%12.32M | -47.54%16.71M | -54.68%15.77M | -54.68%15.77M | -32.76%21.94M | -31.52%25.34M | -22.95%31.85M |
| Free cash flow | 37.08%-12.61M | 7.90%-5.71M | 34.08%-2.58M | 5.80%-4.86M | 111.44%545K | -61.29%-20.04M | -8,467.47%-6.2M | -14.57%-3.91M | -36.58%-5.16M | 2.62%-4.77M |
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data